Figure S5_2 from Integrative Kinome Profiling Identifies mTORC1/2 Inhibition as Treatment Strategy in Ovarian Clear Cell Carcinoma

MLA

Steven de Jong, et al. Figure S5_2 from Integrative Kinome Profiling Identifies MTORC1/2 Inhibition as Treatment Strategy in Ovarian Clear Cell Carcinoma. Mar. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d287ebc3fbaefb661cbb303f586301ba&authtype=sso&custid=ns315887.

APA

Steven de Jong, Ate G.J. van der Zee, René Bernards, Lorenza Mittempergher, Beata Spiewankiewicz, Jolanta Kupryjanczyk, E. Ioana Braicu, James Brenton, Els van Nieuwenhuysen, Ignace Vergote, Helga B. Salvesen, Michael J. Birrer, Anna K.L. Reyners, Roelof J.C. Kluin, Hiroaki Itamochi, Desiree Weening, Evelien W. Duiker, Annemiek M.C. Gennissen, E. Marielle Hijmans, … Joseph J. Caumanns. (2023). Figure S5_2 from Integrative Kinome Profiling Identifies mTORC1/2 Inhibition as Treatment Strategy in Ovarian Clear Cell Carcinoma.

Chicago

Steven de Jong, Ate G.J. van der Zee, René Bernards, Lorenza Mittempergher, Beata Spiewankiewicz, Jolanta Kupryjanczyk, E. Ioana Braicu, et al. 2023. “Figure S5_2 from Integrative Kinome Profiling Identifies MTORC1/2 Inhibition as Treatment Strategy in Ovarian Clear Cell Carcinoma,” March. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d287ebc3fbaefb661cbb303f586301ba&authtype=sso&custid=ns315887.